Search

Your search keyword '"Klivenyi, P."' showing total 140 results

Search Constraints

Start Over You searched for: Author "Klivenyi, P." Remove constraint Author: "Klivenyi, P." Language english Remove constraint Language: english
140 results on '"Klivenyi, P."'

Search Results

1. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

3. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.

6. Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study

7. A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report

12. The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias

13. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

15. Correction to: Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study

16. Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy

19. Non-motor Behavioral Alterations of PGC-1α-Deficient Mice – A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression

20. Language Deficits in Pre-Symptomatic Huntington's Disease: Evidence from Hungarian

23. Mice lacking alpha-synuclein are resistant to mitochondrial toxins

24. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase

25. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

26. Manganese Superoxide Dismutase Overexpression Attenuates MPTP Toxicity

35. cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

37. SAT 1-1

42. Rivaroxaban for stroke prevention after embolic stroke of undetermined source

45. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

46. Behaviour changes in a transgenic model of Huntington's disease. Behav

49. alpha-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation.

50. Effects of valproate on the dopaminergic system in mice.

Catalog

Books, media, physical & digital resources